References
- 1. Persson G, Andersson K, Krantz I. Symptomatic genital papillomavirus infection in a community: incidence and clinical picture. Acta Obstet Gynecol Scand 1996;75:287-90.
- 2. Chirgwin KD, Feldman J, Augenbraun M, Landesman S, Minkoff H. Incidence of venereal warts in HIV-infected and unifected women. J Infect Dis 1995;172:235-8.
- 3. McClean H, Shann S. A cross-sectional survey of treatment choices for anogenital warts. Int J STD AIDS 2005;16:212-6.
- 4. Lacey CJN, Goodall RL, Ragnarson Tennvall G, Maw R, Kinghorn GR, Fisk PG, et al. Randomised controlled trial and economic evaluation of podophyllotoxin solution, podophyllotoxin cream and podophyllin in the treatment of genital warts. Sex Transm Infect 2003;79:270-5.
- 5. Weinstock H, Berman S, Cates W. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Prospect Sex Reprod Health 2004;36(1):6-10.
- 6. Shelton TB, Jerkins GR, Noe HN. Condylomata acuminata in the pediatric patient. J Urol 1986;135(3):548-9.
- 7. Ciuffo G. Inesto positiv con filtrado di verrucae volgare. G Ital Mal Venereol 1907;48:12-7.
- 8. Zur Hansen H. Condyloma acuminata and human genital cancer. Cancer Res 1976;36:530.
- 9. Scheinfeld N, Lehman DS. An evidence-based review of medical and surgical treatments of genital warts. Dermatol Online J 2006;12(3):5.
- 10. Nielson CM, Flores R, Harris RB, Abrahamsen M, Papenfuss MR, Dunne EF, et al. Human papillomavirus prevalence and type distribution in male anogenital sites and semen. Cancer Epidemiol Biomarkers Prev 2007;16(6):1107-14.
- 11. Ciconte A, Campbell J, Tabrizi S, Garland S, Marks R. Warts are not merely blemishes on the skin: a study on the morbidity associated with having viral cutaneous warts. Aust J Dermatol 2003;44:169-73.
- 12. Futterman DC. HIV and AIDS in adolescents. Adolesc Med 2004;15:369-91.
- 13. Brown DR, Schroeder JM, Bryan JT, Stoler MH, Fife KH. Detection of multiple human papillomavirus types in Condylomata acuminata lesions from otherwise healthy and immunosuppressed patients. J Clin Microbiol 1999;37:3316-22.
- 14. Elbasha EH, Galvani AP.Vaccination against multiple HPV types. Math Biosci 2005;197:88-117.
- 15. Partridge JM, Koutsky LA. Genital human papillomavirus infection in men. Lancet Infect Dis 2006;6:21-31.
- 16. Moscicki AB. Impact of HPV infection in adolescent populations. J Adolesc Health 2005;37:S3-S9.
- 17. Sonnex C, Strauss S, Gray JJ. Detection of human papillovirus DNA on the fingers of patients with genital warts. Sex Transm Infect 1999;75:317-9.
- 18. Marrazzo JM, Koutsky LA, Kiviat NB, Kuypers JM, Stine K. Papanicolaou test screening and prevalence of genital human papillomavirus among women who have sex with women. Am J Public Health 2001;91:947-52.
- 19. Obalek S, Jablonska S, Orth G. Warts and HPV-related squamous cell tumors of the genitoanal region in children. In: Gross G, von Krogh G, eds. Human papillomavirus infections in dermatovenerology. Bocca Raton: CRC-Press; 1997:305-14.
- 20. Moscicki AB, Shiboski S, Broering J, Powell K, Clayton L, Jay N, et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr 1998;132:277-84.
- 21. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995;87(11):796-802.
- 22. Rubin MA, Kleter B, Zhou M, Ayala G, Cubilla AL, Quint WG, et al. Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol 2001;159:1211-8.
- 23. Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA, et al. Penile cancer: importance of circumcision, human papillomavirus and smoking in situ and invasive disease. Int J Cancer 2005;116:606-16.
- 24. Strickler HD, Schiffman MH, Shah KV, Rabkin CS, Schiller JT, et al. A survay of human papillomavirus 16 antibodies in patient with epithelial cancers. Eur J Cancer Prev 1998;7:305-13.
- 25. Dupin N. Genital warts. Clin Dermatol 2004;22:481-6.
- 26. Giuliano AR, Nielson CM, Flores R, Dunne EF, Abrahamsen M, Papenfuss MR, et al. The optimal anatomic sites for sampling heterosexual men for human papillomavirus (HPV) detection: the HPV detection in men study. J Infect Dis 2007;196(8):1146-52.
- 27. Skerlev M, Grce M, Sirotković-Skerlev M, Husnjak K, Lipozenčić J. Human papillomavirus male genital infections: clinical variations and the significance of DNA typing. Clin Dermatol 2002;20:173-8.
- 28. Aynaud O, Ionesco M, Barrasso R. Penile intraepithelial neoplasia: specific clinical features correlate with histologic and virologic findings. Cancer 1994;74:1762-7.
- 29. Noel JC, Vandenbossche M, Peny MO, Sassine A, de Dobbeleer G, Schulman CC, et al. Verrucous carcinoma of the penis: importance of human papillomavirus typing for diagnosis and therapeutic decision. Eur Urol 1992;22:83-5.
- 30. Trombetta LJ, Place RJ. Giant condyloma acuminata of the anorectum: trends in epidemiology and management: report of a case and review of the literature. Dis Colon Rectum 2001;44:1878-86.
- 31. Antony FC, Ardern-Jones M, Evans AV, Rosenbaum T, Russell-Jones R. Giant condyloma of Buschke-Loewenstein in association with erythroderma. Clin Exp Dermatol 2003;28(1):46-9.
- 32. Sexually trasmitted diseases treatment guidelines 2002. Center for Disease Control and Prevention. MMWR Recomm Rep 2002;51:1-78.
- 33. Kodner CM, Nasraty S. Management of genital warts. Am Fam Physician 2004;70:2335-42.
- 34. Chan EL, Kingston MA, Carlin EM. The laboratory diagnosis of common genital viral infections. J Fam Plan Reprod Health Care 2004;30(1):24-5.
- 35. Dunne EF, Burstein GR, Stone KM. Anogenital human papilomavirus infection in males. Adolesc Med 2003;14(3):613-32.
- 36. Wiley DJ, Douglas J, Beutner K, Cox T, Fife K, Moscicki AB, et al. External genital warts: diagnosis, treatment and prevention. Clin Infect Dis 2002;35(Suppl 2):210-24.
- 37. Lacey CJN. Therapy for genital human papillomavirusrelated disease. J Clin Virol 2005;32S:S82-S90.
- 38. Riva JM, Sedlacek TV, Cunnane MF, Mangan CE. Extended laser vaporization in the treatment of subclinical papillomavirus infection of the lower genital tract. Obstet Gynecol 1989;73:25-30.
- 39. Beutner KR, Ferenczy A. Therapeutic approaches to genital warts. Am J Med 1997;102(5A):28-37.
- 40. Gupta AK, Cherman AM, Tyring SK. Viral and nonviral uses of imiquimod: a review. J Cutan Med Surg 2004;8(5):338-52.
- 41. Garland SM, Sellors JW, Wikstrom A, Petersen CS, Aranda C, Aractingi S, et al. Imiquimod 5% cream is a safe and effective self-applied treatment for anogenital warts: results of an open-label, multicentre phase IIIB trial. Int J STD AIDS 2001;12:722-9.
- 42. Abdullah AN, Walzman M, Wade A. Treatment of external genital warts comparing cryotherapy (liguid nitrogen) and trichloracetic acid. Sex Transm Dis 1993;20:344-5.
- 43. Krebs HB. Treatment of extensive vulvar condylomata acuminata with topical 5-fluorouracil. South Med J 1990;83:761-4.
- 44. Snoeck R, Bossens M, Parent D, Delaere B, Degreef H, Van Ranst M. Phase II double-blind, placebo-controlled study of the safety and efficacy of cidofovir topical gel for the treatment of patients with human papillomavirus infection. Clin Infect Dis 2001;33:597-602
- 45. Dogra S, Kumar B. Circumcision in genital warts-lets us not forget! Sex Transm Infect 2003;79:265.
- 46. Moresi JM, Herbert CR, Cohen BA. Treatment of anogenital warts in children with topical 0,05 podofilox gel and 5% imiquimod cream. Pediatr Dermatol 2001;18(5):448-50.
- 47. Schaen L, Mercurio MG. Treatment of human papilloma virus in a 6-month-old infant with imiquimod 5% cream. Pediatr Dermatol 2001;18(5):450-2.
- 48. Gunter J. Genital and perianal warts: new treatment opportunities for human papillomavirus infection. Am J Obstet Gynecol 2003;189:S3-S11.
- 49. Lipke MM. An armamentarium of warts treatments. Clin Med Res 2006;4 (4):273-93.
- 50. Sherrard J, Riddell L. Comparison of the effectiveness of commonly used clinic-based treatments for external genital warts. Int J STD AIDS 2007;18:365-8.
- 51. Douglas JM, Eron LJ, Judson FN, Rogers M, Alder MB, Taylor E, et al. A randomized trial of combination therapy with intralesional interferon alpha 2b and podophyllin versus podophyllin alone for the therapy of anogenital warts. J Infect Dis 1990;162(1):52-9.
- 52. Cardamakis E, Kotoulas IG, Relakis K, Metalinos K, Michopoulos J, Stathopoulos E, et al. Comparative study of systemic interferon alpha-2A plus isotretinoin versus isotretinoin in the treatment of recurrent condyloma acuminatum in men. Urology 1995;45(5):857-60.
- 53. Orlando G, Fasolo MM, Beretta R, Merli S, Cargnel A. Combined surgery and cidofovir is an effective treatment for genital warts in HIV-infected patients. AIDS 2002;16:447-50.
- 54. Castellsague X, Bosch FX, Munoz N, Meijer CJ, Shah KV, de Sanjose S, et al. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med 2002;346:1105-12.
- 55. Skjeldestad FE, et al. Prophylactic quadrivalent human papillomavirus (HPV) (types 6,11,16,18) L1 virus- like particle (VLP) vaccine (GardasilTM ) reduces cervical intraepithelial neoplasia (CIN) 2/3 risk [Abstract] 43rd Annual Meeting of Infectious Diseases Society of America; October 2005, San Francisco, CA, USA.
- 56. Tjalma WAA, Van Damme P. Who should be vaccinated against human papillomavirus? Int J Gynecol Cancer 2006;16:1489-99.
- 57. Goldstone SE, Palefsky JM, Winnett MT, Neefe JR. Activity of HspE7, a novel immunotherapy, in patient with anogenital warts. Dis Colon Rectum 2002;45:502-7.